A. Moers

发表

Inflammation-induced fibrosis in skeletal muscle of female carriers of Duchenne muscular dystrophy

H. Goebel, W. Stenzel, C. Preusse, 2019, Neuromuscular Disorders.

Antisense oligonucleotides and short interfering RNAs silencing the cyclin-dependent kinase inhibitor p21 improve proliferation of Duchenne muscular dystrophy patients’ primary skeletal myoblasts

Hanns Lochmüller, S. Endesfelder, A. Moers, 2004, Journal of Molecular Medicine.

Identification of transcripts from a subtraction library which might be responsible for the mild phenotype in an intrafamilially variable course of Duchenne muscular dystrophy

B. Uhlenberg, I. Koch, A. Moers, 2003, Human Genetics.

New mutations in the ATM gene and clinical data of 25 AT patients

T. Dörk, I. Demuth, K. Chrzanowska, 2011, neurogenetics.

Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation

A. Uitterlinden, T. Visser, H. Biebermann, 2004, The Lancet.

Facing the genetic heterogeneity in neuromuscular disorders: Linkage analysis as an economic diagnostic approach towards the molecular diagnosis

M. Vorgerd, H. Lochmüller, A. Huebner, 2006, Neuromuscular Disorders.

Ataxia, Intellectual Disability, and Ocular Apraxia with Cerebellar Cysts: A New Disease?

E. Bertini, T. Huisman, K. Zerres, 2013, The Cerebellum.

Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy

T. Braun, D. Mennerich, M. Schuelke, 2000, Neuromuscular Disorders.

Atypical manifestation of childhood primary cerebral lymphoma restricted to the leptomeninges

B. Uhlenberg, I. Scheer, D. Berdel, 2005, European Journal of Pediatrics.

Minimal clinical expression of the holoprosencephaly spectrum and of Currarino syndrome due to different cytogenetic rearrangements deleting the sonic hedgehog gene and the HLXB9 gene at 7q36.3

D. Horn, A. Moers, H. Tönnies, 2004, American journal of medical genetics. Part A.

CNS Disease as the Main Manifestation of Hemophagocytic Lymphohistiocytosis in Two Children

F. Hanefeld, W. Schulz-Schaeffer, K. Rostásy, 2004, Neuropediatrics.

Variable Course of Canavan Disease in Two Boys with Early Infantile Aspartoacylase Deficiency

R. Schutgens, D. Scheffner, A. Moers, 1991, Developmental medicine and child neurology.

Congenital disorder of glycosylation type 1a in a macrosomic 16-month-old boy with an atypical phenotype and homozygosity of the N216I mutation

T. Marquardt, A. Moers, L. Neumann, 2003, European Journal of Pediatrics.

Risk factors for latex allergy in patients with spina bifida

B. Niggemann, U. Wahn, D. Scheffner, 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Dystrophinopathy in a boy with Chediak–Higashi syndrome

R. Cohn, G. Stoltenburg‐Didinger, A. Moers, 1997, Neuromuscular Disorders.

Delayed or late-onset type II glycogenosis with globular inclusions

H. Goebel, M. Sharma, G. Stoltenburg‐Didinger, 2005, Acta Neuropathologica.

A novel 1p31.3p32.2 deletion involving the NFIA gene detected by array CGH in a patient with macrocephaly and hypoplasia of the corpus callosum

B. Ertl-Wagner, H. Voss, A. Moers, 2010, European Journal of Pediatrics.

Abuse as a Cause of Childhood Fractures.

J. Fegert, A. Moers, B. Frericks, 2018, Deutsches Arzteblatt international.

Comparison of three immunoassays for diagnosing sensitization to latex in children with spina bifida

B. Niggemann, U. Wahn, A. Moers, 1996, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome

K. K. Yong, N. Risch, Hua Tang, 2003, Nature Genetics.

Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy

D. Scheffner, A. Moers, P. Möller, 1997, Acta paediatrica.

Increased mRNA expression of tissue inhibitors of metalloproteinase-1 and -2 in Duchenne muscular dystrophy

D. Schuppan, M. Schuelke, G. Stoltenburg‐Didinger, 2005, Acta Neuropathologica.

Ataxia, Intellectual Disability, and Ocular Apraxia with Cerebellar Cysts: A New Disease?

E. Bertini, T. Huisman, K. Zerres, 2014, The Cerebellum.

Cranial ultrasound findings in aspartoacylase deficiency (Canavan disease)

D. Scheffner, A. Moers, C. Bührer, 2005, Pediatric Radiology.

The triad in abusive head trauma—a clinical perspective

J. Fegert, A. Moers, C. Greeley, 2019, Rechtsmedizin.

Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

M. Main, A. Manzur, A. Childs, 2023, The Lancet Neurology.

Camptocormia in an adolescent.

A. von Moers, A. Moers, E. Pfeiffer, 2000, Journal of the American Academy of Child and Adolescent Psychiatry.